Results 211 to 220 of about 14,357 (275)

Tranexamic acid inhibits group A streptococci-mediated fibrinolysis <i>in vitro</i> and modulates host immune cells <i>in vivo</i>. [PDF]

Front Immunol
Possehl M, Vasudevan P, Schenk S, Maletzki C, David R, Kreikemeyer B, Oehmcke-Hecht S.   +6 more
europepmc   +1 more source

Effectiveness and safety of low-dose intraoperative tranexamic acid in cardiac surgery: a retrospective before-and-after study. [PDF]

BMC Anesthesiol
Chung J, Kim IJ, Ju JW, Hong CH, Cho YJ, Jeon Y, Nam K.   +6 more
europepmc   +1 more source

Surgical intervention with cardiopulmonary bypass in a patient with von Willebrand disease. [PDF]

BMC Anesthesiol
Loskutov OA, Ptašekas J, Markov YI, Tkachenko DO, Korotchuk NV, Loskutov DO, Todurov BM, Maruniak SR.   +7 more
europepmc   +1 more source

Total Laparoscopic Hysterectomy in Factor XI Deficiency: A Case Report. [PDF]

Cureus
Ortiz-Villanueva BJ, Lopez-Chavez AG, Mendoza-Torres A, Bravo-Rodriguez LM, Interián-Alvarez FJ.   +4 more
europepmc   +1 more source

Efficacy and safety of tranexamic acid in cardiac surgery: a systematic review and network meta-analysis. [PDF]

BMC Anesthesiol
Pan X, Tang M, Xu Z, Yu H, Huang J, Liang P.   +5 more
europepmc   +1 more source

Investigating PolySTAT's role in clot contraction and fibrin network mechanics.

Biomater Sci
Pichon TJ, Corrigan T, Ling M, Dhawan M, Tobiasch A, Bachler M, Hermann M, Fries D, Armstrong M, Pun SH, White NJ.   +10 more
europepmc   +1 more source

Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study☆ [PDF]

European Journal of Cardio-thoracic Surgery, 2007
Objective: Postoperative bleeding is still one of the most common complications of cardiac surgery. Antifibrinolytic agents successfully reduce bleeding, but there are controversies concerning adverse effects after their systemic use.
Igor Rudez
exaly   +2 more sources